{"data":[{"accessionNo":"0000940594-26-000049","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"ORBIS INVESTMENT MANAGEMENT LTD","reportingCik":null,"personType":"FI","sharesOwned":5433344,"percentOfClass":5.6,"filedAt":"2026-08-14"},{"accessionNo":"0000940594-26-000049","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Allan Gray Australia Pty Ltd","reportingCik":null,"personType":"FI","sharesOwned":15817,"percentOfClass":0,"filedAt":"2026-08-14"},{"accessionNo":"0002012383-26-002146","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7987262,"percentOfClass":8.3,"filedAt":"2026-07-27"},{"accessionNo":"0000940594-26-000027","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"ORBIS INVESTMENT MANAGEMENT LTD","reportingCik":null,"personType":"FI","sharesOwned":6090194,"percentOfClass":6.3,"filedAt":"2026-05-15"},{"accessionNo":"0000940594-26-000027","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Allan Gray Australia Pty Ltd","reportingCik":null,"personType":"FI","sharesOwned":15817,"percentOfClass":0,"filedAt":"2026-05-15"},{"accessionNo":"0001422849-26-000051","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital World Investors","reportingCik":null,"personType":"IA","sharesOwned":4929428,"percentOfClass":5.1,"filedAt":"2026-05-14"},{"accessionNo":"0001104659-26-052492","formType":"SCHEDULE 13G/A","amendmentNo":13,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":11313623,"percentOfClass":11.79,"filedAt":"2026-04-30"},{"accessionNo":"0001104659-26-052492","formType":"SCHEDULE 13G/A","amendmentNo":13,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":"H17182108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":11313623,"percentOfClass":11.79,"filedAt":"2026-04-30"},{"accessionNo":"0000940594-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"ORBIS INVESTMENT MANAGEMENT LTD","reportingCik":null,"personType":"FI","sharesOwned":5934328,"percentOfClass":6.2,"filedAt":"2026-02-17"},{"accessionNo":"0000940594-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Allan Gray Australia Pty Ltd","reportingCik":null,"personType":"FI","sharesOwned":15817,"percentOfClass":0,"filedAt":"2026-02-17"},{"accessionNo":"0001562230-26-000001","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2026-01-30","reportingPerson":"Capital International Investors","reportingCik":null,"personType":"IA","sharesOwned":1186794,"percentOfClass":1.2,"filedAt":"2026-02-05"},{"accessionNo":"0000940594-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"ORBIS INVESTMENT MANAGEMENT LTD","reportingCik":null,"personType":"FI","sharesOwned":4974125,"percentOfClass":5.5,"filedAt":"2025-11-14"},{"accessionNo":"0000940594-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Allan Gray Australia Pty Ltd","reportingCik":null,"personType":"FI","sharesOwned":7960,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-106355","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":9786973,"percentOfClass":10.76,"filedAt":"2025-11-04"},{"accessionNo":"0001104659-25-106355","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001674416","issuerName":"CRISPR Therapeutics AG","ticker":"CRSP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":9786973,"percentOfClass":10.76,"filedAt":"2025-11-04"}],"updatedAt":"2026-10-14T20:02:48.915Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}